Key result
Low-dose, fixed-dose combination antihypertensive therapy may represent a valuable option to initiate treatment and improve blood pressure control with minimal side effects compared to monotherapy.
Why the study?
Does low-dose, fixed-dose combination antihypertensive therapy improve blood pressure control and compliance compared to monotherapy in hypertensive patients?
Does low-dose, fixed-dose combination antihypertensive therapy improve blood pressure control and compliance compared to monotherapy in hypertensive patients?
Low-dose, fixed-dose combination therapy is a valuable option for initiating treatment and managing hypertensive patients unresponsive to monotherapy.
Answers are grounded in this paper and cite their sources.
May support initial low-dose combinations in hypertension; leaves open confirmation versus monotherapy in randomized trials.
The pharmacological treatment of hypertension allows one to reduce substantially the risk of developing a cardiovascular complication. It appears more and more important to bring blood pressure to normal values in order to get the maximal benefit from antihypertensive therapy. Blood pressure lowering drugs make it possible to control blood pressure in about half of the patients when administered as monotherapy. The fraction of patients with a normal blood pressure can be markedly increased by combining drugs acting by different mechanisms. Low doses of antihypertensive agents are generally enough when coadministered. This helps to keep the incidence of side effects minimal and facilitates the patient's compliance with long-term treatment. Low-dose, fixed-dose combination therapy may therefore represent a valuable option not only to treat hypertensive patients unresponsive to drugs given as monotherapy, but also to initiate the treatment.
No takes yet. Share an insight, caveat, or question.
Waeber et al. (1997) conducted a review in Hypertension. Low-dose, fixed-dose combination antihypertensive therapy vs. Monotherapy was evaluated. Low-dose, fixed-dose combination antihypertensive therapy may represent a valuable option to initiate treatment and improve blood pressure control with minimal side effects compared to monotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: